Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / pandemic - Page 64

pandemic

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection
COVID-19 | Life Science History | Nanotechnology | Vaccine

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection

On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…

Read More HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injectionContinue

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine

On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…

Read More The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccineContinue

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials
COVID-19 | Life Science History | Vaccine

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials

On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…

Read More HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trialsContinue

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
COVID-19 | Life Science History | Vaccine

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…

Read More Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19Continue

RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
Biotechnology | COVID-19 | Therapeutics

RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia

On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…

Read More RedHill Biopharma received approval for phase 2/3 COVID-19 study in RussiaContinue

Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19
COVID-19 | FDA | Life Science History

Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19

On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…

Read More Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19Continue

Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
COVID-19 | Genomics | Life Science History

Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research

On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…

Read More Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic researchContinue

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics

On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…

Read More Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeuticsContinue

Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
COVID-19 | Life Science History

Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19

On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…

Read More Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19Continue

BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19
COVID-19 | Diagnostics

BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19

On Jul. 15, 2020, BD (Becton, Dickinson) announced a commitment from the U.S. Department of Health and Human…

Read More BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19Continue

BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
COVID-19 | Life Science History

BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment

On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…

Read More BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatmentContinue

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza

On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…

Read More Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenzaContinue

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore
COVID-19 | Life Science History

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore

On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinメs Office of the…

Read More Philanthropic gifts funded COVID-19 pilot research projects at Einstein and MontefioreContinue

Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility
Biotechnology | COVID-19 | Diagnostics | Genomics | Non-Profit Research

Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility

On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….

Read More Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibilityContinue

Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
Biotechnology | COVID-19 | Therapeutics

Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2

On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…

Read More Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2Continue

WHO and UNICEF warn of a decline in vaccinations during COVID-19
COVID-19 | Life Science History | Vaccine | WHO

WHO and UNICEF warn of a decline in vaccinations during COVID-19

On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…

Read More WHO and UNICEF warn of a decline in vaccinations during COVID-19Continue

More than 150 countries engaged in COVID-19 vaccine global access facility
COVID-19 | Non-Profit Research | Vaccine

More than 150 countries engaged in COVID-19 vaccine global access facility

On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…

Read More More than 150 countries engaged in COVID-19 vaccine global access facilityContinue

COVID-19 antibody tests evaluated as diagnostic test in low-resource settings
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | WHO

COVID-19 antibody tests evaluated as diagnostic test in low-resource settings

On Jul. 15, 2020, scientists at Washington University School of Medicine in St. Louis reported they had joined…

Read More COVID-19 antibody tests evaluated as diagnostic test in low-resource settingsContinue

Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
Biotechnology | COVID-19 | Therapeutics

Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19

On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…

Read More Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19Continue

Experimental COVID-19 vaccine safe, generated immune response
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

Experimental COVID-19 vaccine safe, generated immune response

On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…

Read More Experimental COVID-19 vaccine safe, generated immune responseContinue

CDC called on Americans to wear masks to prevent COVID-19 spread
CDC | COVID-19 | Life Science History

CDC called on Americans to wear masks to prevent COVID-19 spread

On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…

Read More CDC called on Americans to wear masks to prevent COVID-19 spreadContinue

CDC called on Americans to wear masks to prevent COVID-19 spread
CDC | COVID-19 | Life Science History

CDC called on Americans to wear masks to prevent COVID-19 spread

On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…

Read More CDC called on Americans to wear masks to prevent COVID-19 spreadContinue

HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
COVID-19 | Life Science History | Vaccine

HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2

On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…

Read More HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2Continue

Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA
COVID-19 | Life Science History | Vaccine

Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA

On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…

Read More Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPAContinue

Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia
COVID-19 | Life Science History

Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia

On Jul. 14, 2020, Rigel Pharmaceuticals announced the initiation of an investigator-sponsored tria being conducted by Imperial College…

Read More Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumoniaContinue

Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoメs COVID-19 vaccine candidate
COVID-19 | FDA | Life Science History

Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoメs COVID-19 vaccine candidate

On Jul. 14, 2020, Dynavax Technologies announced that the first participants have been dosed in the Phase 1…

Read More Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoメs COVID-19 vaccine candidateContinue

Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19

On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…

Read More Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19Continue

Pascal Biosciences discovered a cannabinoid that combats Coronavirus
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Pascal Biosciences discovered a cannabinoid that combats Coronavirus

On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…

Read More Pascal Biosciences discovered a cannabinoid that combats CoronavirusContinue

Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assays
COVID-19 | Life Science History

Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assays

On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…

Read More Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assaysContinue

Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths
COVID-19 | Life Science History | NIH | Vaccine

Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths

On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…

Read More Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deathsContinue

Page navigation

Previous PagePrevious 1 … 62 63 64 65 66 … 98 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search